Similarly, a role for the CRCX5-CXCL13 axis in the TME in NSCLC has been suggested based on mouse studies and tissue and tumor samples from patients, and this signaling pathway has been implicated in the promotion of lung tumor progression [55]. This evidence concerns the gene CXCL13 and non-small cell lung carcinoma.